These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2900818)

  • 21. [Characteristics and clinical use of esmolol].
    Ravussin P
    Minerva Anestesiol; 1992 Apr; 58(4 Suppl 1):77-9. PubMed ID: 1352393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of myocardial reperfusion injury by high-dose beta-blockade with esmolol.
    Geissler HJ
    Thorac Cardiovasc Surg; 2002 Dec; 50(6):367-72. PubMed ID: 12457318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of myocardial ischemia during coronary occlusion by ultrashort-acting beta adrenergic blockade.
    Labovitz AJ; Barth C; Castello R; Ojile M; Kern MJ
    Am Heart J; 1991 May; 121(5):1347-52. PubMed ID: 1673282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bolus administration of esmolol for the treatment of intraoperative myocardial ischaemia.
    Miller DR; Martineau RJ
    Can J Anaesth; 1989 Sep; 36(5):593-7. PubMed ID: 2571423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy.
    Zvara DA; Brooker RF; McCall WV; Foreman AS; Hewitt C; Murphy BA; Royster RL
    Convuls Ther; 1997 Sep; 13(3):165-74. PubMed ID: 9342132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
    Kloner RA; Kirshenbaum J; Lange R; Antman EM; Braunwald E
    Am J Cardiol; 1985 Oct; 56(11):40F-48F. PubMed ID: 2864848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esmolol in acute ischemic syndromes.
    Mitchell RG; Stoddard MF; Ben-Yehuda O; Aggarwal KB; Allenby KS; Trillo RA; Loyd R; Chang CT; Labovitz AJ
    Am Heart J; 2002 Nov; 144(5):E9. PubMed ID: 12422138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basic pharmacology of esmolol.
    Gorczynski RJ
    Am J Cardiol; 1985 Oct; 56(11):3F-13F. PubMed ID: 2864846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esmolol (Brevibloc) to assess dynamic subpulmonary stenosis in a child after repair of complete transposition: a case report.
    Sacks EJ; Laddu AR
    Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):117-9. PubMed ID: 2566585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac arrest after esmolol administration: a review of acute beta-blocker toxicity.
    Litman RS; Zerngast BA
    J Am Osteopath Assoc; 1996 Oct; 96(10):616-8. PubMed ID: 8936932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled beta-receptor blockade with esmolol and flestolol.
    Murthy VS; Frishman WH
    Pharmacotherapy; 1988; 8(3):168-82. PubMed ID: 2902602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent.
    Klein G; Wirtzfeld A; Alt E; Steck J; Saunders R; Hulse J; Kartzinel R; Lee R; Laddu AR
    Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):112-7. PubMed ID: 6142005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonthrombolytic intervention in acute myocardial infarction.
    Kirshenbaum JM
    Am J Cardiol; 1989 Jul; 64(4):25B-28B. PubMed ID: 2568748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery.
    Hilleman DE; Reyes AP; Mooss AN; Packard KA
    Curr Med Res Opin; 2003; 19(5):376-82. PubMed ID: 13678474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
    Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo.
    Iliodromitis EK; Tasouli A; Andreadou I; Bofilis E; Zoga A; Cokkinos P; Kremastinos DT
    Eur J Pharmacol; 2004 Sep; 499(1-2):163-9. PubMed ID: 15363963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.
    Felix SB; Stangl V; Kieback A; Doerffel W; Staudt A; Wernecke KD; Baumann G; Stangl K
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):666-71. PubMed ID: 11602813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Esmolol attenuation of hemodynamic changes in resuscitation of hypertensive and coronary patients].
    Marty J; Kirsteter P; Cantineau JP; Couderc E; Lefèvre P; Lagoueyte JF; Desmonts JM
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R95. PubMed ID: 2574969
    [No Abstract]   [Full Text] [Related]  

  • 39. Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol.
    Balcells J; Rodríguez M; Pujol M; Iglesias J
    Pediatr Cardiol; 2004; 25(2):160-2. PubMed ID: 15046104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis.
    Gore DC; Wolfe RR
    Surgery; 2006 May; 139(5):686-94. PubMed ID: 16701103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.